View:
United States securities and exchange commission logo
May 13, 2020
Daniel P. Gold, Ph.D.
President & Chief Executive Officer
MEI Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego, California 92130
Re: MEI Pharma, Inc.
Registration
Statement on Form S-3
Filed May 7, 2020
File No. 333-238056
Dear Dr. Gold:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Irene
Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Finnbarr D. Murphy